Pancreatic Enzyme Replacement Therapy in patients after Major Upper Gastro-Intestinal Operations (PERTUGI) - A Randomized Controlled Trial to Assess Weight Change, Quality of Life, and Faecal Elastase in patients receiving enzyme supplementation with Creon (Trademark)

Trial Profile

Pancreatic Enzyme Replacement Therapy in patients after Major Upper Gastro-Intestinal Operations (PERTUGI) - A Randomized Controlled Trial to Assess Weight Change, Quality of Life, and Faecal Elastase in patients receiving enzyme supplementation with Creon (Trademark)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 08 Mar 2017

At a glance

  • Drugs Pancrelipase (Primary)
  • Indications Exocrine pancreatic insufficiency
  • Focus Therapeutic Use
  • Acronyms PERTUGI
  • Most Recent Events

    • 22 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top